FDA adds new heart warning to Sanofi’s Multaq

In CategoryCardiovascular Health, Drugs and Drug Companies
ByRuss Bianchi

Federal health officials have added new safety warnings to the heart rhythm drug Multaq after company studies linked the pill to higher rates of heart attack, stroke and death in a subset of patients.

FDA adds new heart warning to Sanofi’s Multaq

Share